Our Services
Medical Information
Helpful Resources
Published on: 9/24/2026
Muscle aches, tenderness, or weakness while taking atorvastatin are usually mild and reversible, but you should not stop the medication on your own before speaking with your prescriber, who may lower your dose, switch statins, or check a creatine kinase blood test. Seek urgent care right away if pain is severe, spreads widely, comes with dark or cola-colored urine, fever, or vomiting, since these can signal rhabdomyolysis, a rare but serious muscle breakdown. Other causes, including vitamin D deficiency, thyroid problems, exercise strain, and drug interactions with certain antibiotics, antifungals, or grapefruit juice, are often to blame and change what you should do next. There are several important factors to consider, so review the complete details below before making any decision about your statin.
If you are unsure whether your muscle pain is a harmless side effect or a warning sign, a free, instant, online symptom check can help you sort through your symptoms in minutes, flag red flags that need urgent attention, and show you which next steps and questions to bring to your doctor.
Last reviewed for medical accuracy: 09/24/2026
Atorvastatin is a widely prescribed statin used to lower “bad” LDL cholesterol and reduce the risk of heart attack and stroke. Many people take atorvastatin 20 mg daily with good results. However, some experience muscle pain, cramps or weakness. This guide explains why muscle pain happens, how to track it, and what steps you can take to stay safe and comfortable.
While atorvastatin 20 mg is generally well tolerated, up to 10% of users report muscle-related side effects. Recognizing these early and managing them promptly can help you continue therapy safely.
Statin-related muscle symptoms can range from mild myalgia to rare but serious rhabdomyolysis. Possible reasons include:
It’s important to distinguish between common muscle soreness (from exercise or daily activity) and statin-related muscle issues.
Myalgia (muscle pain)
• Aching, soreness or stiffness without significant rise in creatine kinase (CK)
• Often symmetrical, affecting thighs, shoulders or calves
Myopathy (muscle weakness)
• New weakness or heaviness in muscles
• Difficulty climbing stairs or lifting objects
Rhabdomyolysis (rare but severe)
• Extreme muscle pain and weakness
• Dark, tea-colored urine
• Elevated CK levels, potential kidney damage
If you notice any unusual or severe symptoms—especially dark urine or pronounced weakness—seek medical attention immediately.
Keep a Symptom Diary
Review Your Activity Level
Check Medication Interactions
Monitor Other Risk Factors
Always consult your healthcare provider before making changes to a prescribed statin regimen. Your doctor may recommend:
Complement medical advice with healthy habits to manage cholesterol and muscle health:
Stop atorvastatin and seek immediate medical attention if you experience:
These signs may indicate rhabdomyolysis, which requires prompt evaluation.
To get personalized guidance before your next appointment, consider a free, online symptom check, using the doctor approved Ubie Symptom Checker. This tool can help you sort symptoms and decide if you need urgent care or a routine follow-up.
free, online symptom check, using the doctor approved Ubie Symptom Checker
Most people tolerate statins well, and the cardiovascular benefits often outweigh side-effect risks. With careful monitoring and good communication with your healthcare team, you can find a plan that keeps your cholesterol in check without compromising comfort.
If you experience any life-threatening or serious symptoms, speak to a doctor right away. And for any concerns about muscle pain or medication, always discuss them with your healthcare provider before making changes.
(References)
* Fitzgerald K, Redmond E, Harbor C. Statin-induced Myopathy. Glob Adv Health Med. 2012 May;1(2):32-6. doi: 10.7453/gahmj.2012.1.2.008. PMID: 24278816; PMCID: PMC3833493.
* Collins R, Reith C, Emberson J, Armitage J, Baigent C, Blackwell L, Blumenthal R, Danesh J, Smith GD, DeMets D, Evans S, Law M, MacMahon S, Martin S, Neal B, Poulter N, Preiss D, Ridker P, Roberts I, Rodgers A, Sandercock P, Schulz K, Sever P, Simes J, Smeeth L, Wald N, Yusuf S, Peto R. Interpretation of the evidence for the efficacy and safety of statin therapy. Lancet. 2016 Nov 19;388(10059):2532-2561. doi: 10.1016/S0140-6736(16)31357-5. Epub 2016 Sep 8. PMID: 27616593.
* Baggett MC, Nykamp D. Statin-Associated Bilateral Foot Myopathy. J Pharm Pract. 2020 Dec;33(6):899-902. doi: 10.1177/0897190019857851. Epub 2019 Jun 27. PMID: 31248326.
* Hougaard Christensen MM, Bruun Haastrup M, Øhlenschlaeger T, Esbech P, Arnspang Pedersen S, Bach Dunvald AC, Bjerregaard Stage T, Pilsgaard Henriksen D, Thestrup Pedersen AJ. Interaction potential between clarithromycin and individual statins-A systematic review. Basic Clin Pharmacol Toxicol. 2020 Apr;126(4):307-317. doi: 10.1111/bcpt.13343. Epub 2019 Nov 8. PMID: 31628882.
* Nemati M, Srai M, Rudrangi R. Statin-Induced Autoimmune Myopathy. Cureus. 2021 Feb 26;13(2):e13576. doi: 10.7759/cureus.13576. Epub 2021 Feb 26. PMID: 33815984; PMCID: PMC8007198.
* Cooper-DeHoff RM, Niemi M, Ramsey LB, Luzum JA, Tarkiainen EK, Straka RJ, Gong L, Tuteja S, Wilke RA, Wadelius M, Larson EA, Roden DM, Klein TE, Yee SW, Krauss RM, Turner RM, Palaniappan L, Gaedigk A, Giacomini KM, Caudle KE, Voora D. The Clinical Pharmacogenetics Implementation Consortium Guideline for SLCO1B1, ABCG2, and CYP2C9 genotypes and Statin-Associated Musculoskeletal Symptoms. Clin Pharmacol Ther. 2022 May;111(5):1007-1021. doi: 10.1002/cpt.2557. Epub 2022 Mar 11. PMID: 35152405; PMCID: PMC9035072.
* Cholesterol Treatment Trialists' Collaboration. Effect of statin therapy on muscle symptoms: an individual participant data meta-analysis of large-scale, randomised, double-blind trials. Lancet. 2022 Sep 10;400(10355):832-845. doi: 10.1016/S0140-6736(22)01545-8. Epub 2022 Aug 29. PMID: 36049498; PMCID: PMC7613583.
* Timmons P, Williamson A, Gibbs V, Torgersen A. Weak legs. Acute Med. 2022;21(3):153-156. doi: 10.52964/AMJA.0917. PMID: 36427216.
* Todorovac N, Krøigård AB, Christiansen AA, Jadou G. Immune-mediated necrotising myopathy after several years of treatment with atorvastatin. Ugeskr Laeger. 2024 Oct 28;186(44). doi: 10.61409/V01240030. PMID: 39534931.
* Acheampong S, Udoyeh C, Darko P, Omeludike EK. Rifaximin-Induced Rhabdomyolysis. Cureus. 2026 Feb;18(2):e104091. doi: 10.7759/cureus.104091. Epub 2026 Feb 22. PMID: 41890483; PMCID: PMC13014114.
We would love to help them too.
For First Time Users
We provide a database of explanations from real doctors on a range of medical topics. Get started by exploring our library of questions and topics you want to learn more about.
Was this page helpful?
Purpose and positioning of servicesUbie Doctor's Note is a service for informational purposes. The provision of information by physicians, medical professionals, etc. is not a medical treatment. If medical treatment is required, please consult your doctor or medical institution. We strive to provide reliable and accurate information, but we do not guarantee the completeness of the content. If you find any errors in the information, please contact us.